Synovir thalidomide: CELG began a Phase II trial

Celgene Corp. (CELG), Warren, N.J. Product: Synovir thalidomide Indication: Chronic intractable diarrhea in HIV-positive patients Status: CELG began a Phase II trial of Synovir thalidomide in the U.K...